Yuwiler A
J Neurochem. 1987 Sep;49(3):806-11. doi: 10.1111/j.1471-4159.1987.tb00965.x.
The alpha-adrenergic agonists phenylephrine and methoxamine, at concentrations that have little effect on pineal N-acetyltransferase activity, markedly enhance stimulation of this enzyme by vasoactive intestinal polypeptide (VIP). This augmentation can be blocked by the alpha 1-adrenergic antagonists phenoxybenzamine and prazosin and, at 10 but not 1 microM, by the alpha 2-antagonist yohimbine. The time course for VIP stimulation is not altered by concomitant alpha-adrenergic stimulation. Augmented activity does not require concomitant alpha-adrenergic stimulation, but alpha-adrenergic agonists must be present for augmentation to be maintained. Phorbol 12,13-diacetate or -dibutyrate but not 4 alpha-phorbol can substitute for phenylephrine, a finding suggesting that protein kinase C is involved in the augmentation. These results are, in general, analogous to alpha-adrenergic magnification of N-acetyltransferase induction by beta-adrenergic agonists.
α-肾上腺素能激动剂去氧肾上腺素和甲氧明在对松果体N-乙酰转移酶活性影响很小的浓度下,能显著增强血管活性肠肽(VIP)对该酶的刺激作用。这种增强作用可被α1-肾上腺素能拮抗剂酚苄明和哌唑嗪阻断,且在10μM而非1μM浓度下可被α2-拮抗剂育亨宾阻断。VIP刺激的时间进程不受同时进行的α-肾上腺素能刺激影响。增强的活性不需要同时进行α-肾上腺素能刺激,但α-肾上腺素能激动剂必须存在才能维持增强作用。佛波醇12,13-二乙酸酯或-二丁酸酯而非4α-佛波醇可替代去氧肾上腺素,这一发现表明蛋白激酶C参与了增强作用。总体而言,这些结果类似于β-肾上腺素能激动剂对N-乙酰转移酶诱导的α-肾上腺素能放大作用。